Table 3 Rank probability analysis of PH with using stains in COPD patients
From: Effectiveness of long-term using statins in COPD – a network meta-analysis
Treatment | SUCRA | sd | 2.50% | median | 97.50% |
|---|---|---|---|---|---|
Atorvastatin | 75.4 | 0.2354 | 0.3 | 0.7 | 1.0 |
Fluvastatin | 76.0 | 0.2616 | 0.3 | 0.7 | 1.0 |
Simvastatin | 48.0 | 0.2299 | 0.3 | 0.3 | 1.0 |
Conventional treatment | 0.6 | 0.0431 | 0.0 | 0.0 | 0.0 |